Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginseng G115 is a **standardized extract of Panax ginseng**, derived from the root of the Asian/Korean ginseng plant and formulated to a precise, reproducible content of active compounds, primarily **ginsenosides**[2][5]. The extract is primarily standardized to a set ginsenoside content and is used mainly to support cognitive function, immune modulation, blood glucose regulation, and general physical endurance, though its efficacy for athletic performance is debated[1][2][3]. Research indicates that G115 can enhance immune responses, increase resistance to colds and influenza, modestly regulate blood glucose, and reduce subjective mental fatigue, with some studies pointing to improved cognitive performance[1][2][3]. The mechanism of action is thought to involve modulation of the hypothalamus-pituitary-adrenal axis, immunomodulation (enhancing natural killer and T helper cell activity), and glycemic control, largely mediated by the ginsenoside constituents[1][2][3]. G115 is considered **widely safe and well-tolerated** with mild and infrequent side effects[1][2][5]. Its efficacy as a supplement is supported by several decades of preclinical and clinical use, mainly in Europe and Asia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginseng G115.